PENTAX Medical Europe to launch single-use bronchoscope

HAMBURG, 26 May 2021 – PENTAX Medical Europe, a leading company in the endoscopic field, has obtained a CE mark for its new single-use bronchoscope – the PulmoONE. This innovative product provides high quality care without compromise in pulmonary care. The PulmoONE is a single-use bronchoscope with superior suction power and HD image quality. 

Simplified workflows

The sterile-packed scopes are ready to use anytime, anywhere, allowing quicker care delivery to the most vulnerable patients. Single-use scopes eliminate wait times between procedures, simplifying overall workflow and patient throughput.

Wolfgang Mayer, Head of Research and Development at PENTAX Medical EMEA, comments: “The single-use bronchoscope was developed in close collaboration with physicians to offer them a solution based on their needs. As part of our Triple Aim program, we continually improve patient outcomes by offering evidence based solutions.”

It is expected the new single-use bronchoscope will be available for clinical use on August 1st, 2021, with full commercial launch to be announced at a later date.

Rainer Burkard, Chief Executive Officer PENTAX Medical EMEA and Commercial Officer AMERICAS, continues: “At PENTAX Medical we are committed to addressing the medical device hygiene challenges by continually innovating products, optimizing processes, and integrating feedback from the market. Our main objectives are to minimize the risk of infection, improve clinical outcomes, and enhance the professional's experience and healthcare productivity within endoscopy. We are proud our portfolio now includes a single-use bronchoscope to enhance infection prevention without compromising on high quality pulmonary care.”